- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Sustainable Track Record
Global Pharmaceuticals & Biotech Sustainable Track Record
Results
65
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
65 companies
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.9b
Produces and sells medicines in China.
600285
CN¥22.97
7D
0.8%
1Y
-7.7%
Asston Pharmaceuticals
Market Cap: ₹743.2m
Manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries.
544445
₹87.30
7D
-6.6%
1Y
n/a
Vistin Pharma
Market Cap: NOK 944.5m
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 21.70
7D
-3.1%
1Y
-22.2%
Anlon Healthcare
Market Cap: ₹6.8b
Manufactures and sells advance pharmaceutical intermediates in India and internationally.
AHCL
₹127.12
7D
0.6%
1Y
n/a
SK Biopharmaceuticals
Market Cap: ₩8.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩108,000.00
7D
6.4%
1Y
-10.4%
Macter International
Market Cap: PK₨16.4b
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
MACTER
PK₨358.15
7D
-7.0%
1Y
179.4%
Highnoon Laboratories
Market Cap: PK₨60.9b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,149.00
7D
0.02%
1Y
47.5%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥29.6b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥44.80
7D
1.8%
1Y
28.5%
Novo Nordisk
Market Cap: DKK 1.6t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 354.95
7D
-1.6%
1Y
-55.7%
Xiamen Amoytop Biotech
Market Cap: CN¥32.0b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥77.31
7D
-3.7%
1Y
-6.2%
Torrent Pharmaceuticals
Market Cap: ₹1.2t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,590.15
7D
2.0%
1Y
7.6%
Lotus Pharmaceutical
Market Cap: NT$80.6b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$292.00
7D
3.5%
1Y
12.1%
Jin Yang Pharmaceutical
Market Cap: ₩66.4b
Engages in the pharmaceutical business in South Korea.
A007370
₩5,530.00
7D
-1.6%
1Y
-5.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥46.8b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥105.28
7D
-0.9%
1Y
86.2%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.4b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥17.02
7D
-1.3%
1Y
-30.1%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م6.8b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م4.48
7D
2.5%
1Y
16.4%
Halozyme Therapeutics
Market Cap: US$7.8b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$66.88
7D
0.3%
1Y
29.7%
Rubicon Research
Market Cap: ₹100.8b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹611.85
7D
n/a
1Y
n/a
Quality Chemical Industries
Market Cap: USh420.0b
Manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh115.00
7D
-2.5%
1Y
109.1%
Shanghai Henlius Biotech
Market Cap: HK$39.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$73.40
7D
10.2%
1Y
232.9%
Neuren Pharmaceuticals
Market Cap: AU$2.8b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$21.39
7D
3.2%
1Y
67.4%
Nirman Agri Genetics
Market Cap: ₹1.1b
Operates as an agri-input company in India.
NIRMAN
₹135.95
7D
-22.6%
1Y
-59.8%
Astonea Labs
Market Cap: ₹1.7b
Manufactures and markets pharmaceutical and cosmetic products under the Glow Up and Regero brand names in India and internationally.
544409
₹160.55
7D
-0.3%
1Y
n/a
Eli Lilly
Market Cap: US$726.2b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$799.57
7D
-1.6%
1Y
-12.1%
Earth Science Tech
Market Cap: US$46.6m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.18
7D
9.7%
1Y
-0.5%
Influx Healthtech
Market Cap: ₹4.0b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹174.35
7D
-3.0%
1Y
n/a
May & Baker Nigeria
Market Cap: ₦30.8b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦17.75
7D
4.1%
1Y
161.0%
Bora Pharmaceuticals
Market Cap: NT$80.6b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$648.00
7D
0.5%
1Y
4.5%
Beta Drugs
Market Cap: ₹18.4b
Develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India.
BETA
₹1,820.35
7D
6.1%
1Y
11.9%